We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,154 results
  1. Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response

    Endometrial carcinoma remains a public health concern with a growing incidence, particularly in younger women. Preserving fertility is a crucial...

    Zhe Hu, Zimeng Wu, ... Chaoyang Sun in Nature Genetics
    Article 02 April 2024
  2. CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report

    Background

    Most endometrial cancers are of low histological grade and uterine-confined, with a high 5-year survival rate. However, a small subset of...

    Lan Zhong, Wei Jiang, ... Liang Song in BMC Medical Genomics
    Article Open access 16 June 2023
  3. Development of a novel predictive model for lymph node metastasis in patients with endometrial endometrioid carcinoma

    Background

    Globally, the burden of endometrial endometrioid carcinoma (EEC) increases annually. However, the histological grade of EEC remains...

    **ngdan Guo, Chunhua Lin, ... Mi Tang in BMC Cancer
    Article Open access 20 December 2022
  4. Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO

    Background

    Accurate preoperative molecular and histological risk stratification is essential for effective treatment planning in endometrial cancer....

    Zaher Alwafai, Maximilian Heinz Beck, ... Klaus Pietzner in BMC Cancer
    Article Open access 25 March 2024
  5. Ultrasonographic evaluation of endometrial stripe thickness is insufficient to rule out uterine serous carcinoma

    Purpose

    Uterine serous carcinoma (USC) is a rare endometrial cancer representing less than 10% of uterine cancers but contributing to up to 50% of the...

    Jaime M. Kiff, Mercedes Williams-Weisenberger, ... Amanda S. Bruegl in Cancer Causes & Control
    Article 28 July 2023
  6. Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma

    Objective

    Endocrine therapy is frequently administered in patients with hormone dependent (HR+) metastatic endometrial cancer. ESR1 mutations have...

    Aurélien Drouyer, Ludivine Beaussire, ... Florian Clatot in BMC Cancer
    Article Open access 03 November 2023
  7. Genomic profile of Chinese patients with endometrial carcinoma

    Backgrounds

    Endometrial carcinoma (EC) is one of the most commonly diagnosed gynecologic malignancy in China. However, the genetic profile of Chinese...

    ** Li, **aoqi Li, ... **aohua Wu in BMC Cancer
    Article Open access 20 September 2023
  8. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma

    Background

    PHGDH (Phosphoglycerate Dehydrogenase) is the first branch enzyme in the serine biosynthetic pathway and plays a vital role in several...

    He Zhang, Weimin Kong, ... Shuning Chen in BMC Medical Genomics
    Article Open access 20 February 2023
  9. The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients

    Objective

    This study was designed to investigate the frequency and clinicopathological characteristics of POLE-mutated/ultramutated (POLEmut) in...

    Qing Wu, Nianhai Zhang, **anhe **e in BMC Cancer
    Article Open access 10 November 2022
  10. Intraepithelial lymphocytes are indicators of better prognosis in surgically resected endometrioid-type endometrial carcinomas at early and advanced stages

    Background

    Tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) may be useful prognostic indicators in endometrial cancer....

    Takako Kono-Sato, Kosuke Miyai, ... Hitoshi Tsuda in BMC Cancer
    Article Open access 02 April 2022
  11. Diagnostic value of integrated 18F-FDG PET/MRI for staging of endometrial carcinoma: comparison with PET/CT

    Purpose

    To explore the diagnostic value of integrated positron emission tomography/magnetic resonance imaging (PET/MRI) for the staging of endometrial...

    Yang Yu, Le Zhang, ... Hongzan Sun in BMC Cancer
    Article Open access 01 September 2022
  12. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma

    Background

    S100A2, a member of the S100 protein family, is abnormally expressed and plays a vital role in multiple cancers. However, little is known...

    Qinzhen Zhang, Tianxiang ** Ye in BMC Cancer
    Article Open access 18 January 2022
  13. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular ty** protocols

    Background

    Endometrial carcinoma (EC) is one of the most common gynecological malignancies in China and globally, accounting for the fourth-prevalent...

    Zihui Yang, ** Yang, ... Qin-** Liao in BMC Cancer
    Article Open access 14 March 2023
  14. Prognosis Trend of Grade 2 Endometrioid Endometrial Carcinoma: Toward Grade 1 or 3?

    Although the prognostic significance of grade in endometrial cancer is well known, grade 2 cases have not been evaluated separately in most of the...

    Ghanim Khatib, Umran Kucukgoz Gulec, ... Mehmet Ali Vardar in Pathology & Oncology Research
    Article 02 June 2020
  15. Anaplastic lymphoma kinase overexpression enhances aggressive phenotypic characteristics of endometrial carcinoma

    Background

    Although anaplastic lymphoma kinase (ALK) is overexpressed in several primary solid tumor types, its role in endometrial carcinoma (Em Ca)...

    Ako Yokoi, Yusaku Nakamura, ... Makoto Saegusa in BMC Cancer
    Article Open access 17 August 2023
  16. Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value

    Background

    The endometrial cancer mismatch repair (MMR) deficient subgroup is defined by loss of MSH6, MSH2, PMS2 or MLH1. We compare MMR status in...

    Hege F. Berg, Hilde Engerud, ... Camilla Krakstad in British Journal of Cancer
    Article Open access 08 December 2022
  17. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of “precursor escape”?

    Abstract

    Synchronous endometrial and ovarian carcinomas (SEOCs) that share the same endometrioid histology are generally considered as the result of...

    Cindy Hsuan Weng, Ren-Chin Wu, ... Chyong-Huey Lai in Journal of Molecular Medicine
    Article 25 March 2021
  18. Impact of hormonal contraception on endometrial histology in patients with Lynch syndrome, a retrospective pilot study

    Hormonal contraception (HC) is a well-recognized protection against endometrial cancer (EC) in the general population. It has not been established if...

    Marie Mawet, Clémence Evrevin, ... Nathalie Chabbert-Buffet in Familial Cancer
    Article 30 April 2024
  19. Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer

    Background

    Rates of endometrial cancer (EC) are increasing. For a definitive diagnosis, women undergo various time-consuming and painful medical...

    Paweł Łaniewski, Haiyan Cui, ... Melissa M. Herbst-Kralovetz in Biomarker Research
    Article Open access 02 December 2022
  20. Impact of Different DNA Ploidy Patterns on Endometrial Carcinomas Based on Image Cytometry

    Worldwide, endometrial cancer is one of the most frequently diagnosed malignancies in women and a notable cause of death. The aim of this study was...

    Kosmas Konstantinos, Riga Dimitra, ... Tsiambas Evangelos in Cytology and Genetics
    Article 01 February 2024
Did you find what you were looking for? Share feedback.